Form 8-K - Current report:
SEC Accession No. 0001628280-24-049979
Filing Date
2024-12-05
Accepted
2024-12-05 07:03:53
Documents
38
Period of Report
2024-12-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K avtx-20241205.htm   iXBRL 8-K 25842
2 EX-99.1 ex-991_avtxcorporatepres.htm EX-99.1 30618
6 GRAPHIC ex-991_avtxcorporatepres001.jpg GRAPHIC 95473
7 GRAPHIC ex-991_avtxcorporatepres002.jpg GRAPHIC 155697
8 GRAPHIC ex-991_avtxcorporatepres003.jpg GRAPHIC 141634
9 GRAPHIC ex-991_avtxcorporatepres004.jpg GRAPHIC 126545
10 GRAPHIC ex-991_avtxcorporatepres005.jpg GRAPHIC 116690
11 GRAPHIC ex-991_avtxcorporatepres006.jpg GRAPHIC 155169
12 GRAPHIC ex-991_avtxcorporatepres007.jpg GRAPHIC 50419
13 GRAPHIC ex-991_avtxcorporatepres008.jpg GRAPHIC 149789
14 GRAPHIC ex-991_avtxcorporatepres009.jpg GRAPHIC 124708
15 GRAPHIC ex-991_avtxcorporatepres010.jpg GRAPHIC 138225
16 GRAPHIC ex-991_avtxcorporatepres011.jpg GRAPHIC 141105
17 GRAPHIC ex-991_avtxcorporatepres012.jpg GRAPHIC 121133
18 GRAPHIC ex-991_avtxcorporatepres013.jpg GRAPHIC 179423
19 GRAPHIC ex-991_avtxcorporatepres014.jpg GRAPHIC 140572
20 GRAPHIC ex-991_avtxcorporatepres015.jpg GRAPHIC 178918
21 GRAPHIC ex-991_avtxcorporatepres016.jpg GRAPHIC 179524
22 GRAPHIC ex-991_avtxcorporatepres017.jpg GRAPHIC 69907
23 GRAPHIC ex-991_avtxcorporatepres018.jpg GRAPHIC 43834
24 GRAPHIC ex-991_avtxcorporatepres019.jpg GRAPHIC 196242
25 GRAPHIC ex-991_avtxcorporatepres020.jpg GRAPHIC 36147
26 GRAPHIC ex-991_avtxcorporatepres021.jpg GRAPHIC 141670
27 GRAPHIC ex-991_avtxcorporatepres022.jpg GRAPHIC 37526
28 GRAPHIC ex-991_avtxcorporatepres023.jpg GRAPHIC 31075
29 GRAPHIC ex-991_avtxcorporatepres024.jpg GRAPHIC 118744
  Complete submission text file 0001628280-24-049979.txt   4145229

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avtx-20241205.xsd EX-101.SCH 1850
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avtx-20241205_lab.xml EX-101.LAB 21026
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avtx-20241205_pre.xml EX-101.PRE 12041
40 EXTRACTED XBRL INSTANCE DOCUMENT avtx-20241205_htm.xml XML 2625
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37590 | Film No.: 241527809
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)